4//SEC Filing
Sharei Armon 4
Accession 0001209191-22-003218
CIK 0001604477other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:15 PM ET
Size
7.2 KB
Accession
0001209191-22-003218
Insider Transaction Report
Form 4
Sharei Armon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-01-12$1.81/sh+13,000$23,530→ 285,448 total - Exercise/Conversion
Stock Option
2022-01-12$1.81/sh−13,000$23,530→ 171,937 totalExercise: $1.81Exp: 2026-10-10→ Common Stock (13,000 underlying)
Footnotes (2)
- [F1]Options were exercised and held for tax planning purposes.
- [F2]The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001829463
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:15 PM ET
- Size
- 7.2 KB